Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Narcolepsy Drugs Market


6. Market Share – Global Narcolepsy Drugs Market

6.1 By Disease Type
6.2 By Therapeutic Type
6.3 By End Users
6.4 By Country


7. Disease Type – Global Narcolepsy Drugs Market

7.1 Daytime Extreme Sleepiness
7.2 Cataplexia
7.3 Other Disease type


8. Therapeutic Type – Global Narcolepsy Drugs Market

8.1 Central Nervous Systems Stimulants
8.2 Tricyclic Antidepressants
8.3 Sodium Oxybate
8.4 Selective Serotonin Reuptake Inhibitor
8.5 Others


9. End Users – Global Narcolepsy Drugs Market

9.1 Diagnostics Centers
9.2 Hospitals
9.3 Others


10. Countries – Global Narcolepsy Drugs Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Latin America

10.2.1 Mexico
10.2.2 Brazil

10.3 Europe

10.3.1 United Kingdom
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands

10.4 Asia Pacific

10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia

10.5 Middle East & Africa

10.5.1 United Arab Emirates
10.5.2 South Africa


11. Porter’s Five Forces Analysis – Global Narcolepsy Drugs Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Narcolepsy Drugs Market

12.1.1 Strength
12.1.2 Weakness
12.1.3 Opportunity
12.1.4 Threat


13. Company Analysis – Global Narcolepsy Drugs Market

13.1 Jazz Pharmaceuticals

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Net Sales

13.2 Ligand Pharmaceuticals

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Net Sales

13.3 Novartis AG

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Net Sales

13.4 Takeda Pharmaceutical

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Net Sales

13.5 Teva Pharmaceutical

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Net Sales

13.6 Hikma Pharmaceuticals Plc

13.6.1 Overview
13.6.2 Development
13.6.3 Net Sales

13.7 Harmony Biosciences Holdings

13.7.1 Overview
13.7.2 Development
13.7.3 Net Sales

13.8 Roche Holding AG

13.8.1 Overview
13.8.2 Development
13.8.3 Net Sales

13.9 Johnson & Johnson

13.9.1 Overview
13.9.2 Development
13.9.3 Net Sales



List of Figures

Figure-01: Global – Narcolepsy Drugs Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Narcolepsy Drugs Market (Billion US$), 2024 – 2030
Figure-03: Disease Type – Daytime Extreme Sleepiness Market (Million US$), 2018 – 2023
Figure-04: Disease Type – Forecast for Daytime Extreme Sleepiness Market (Million US$), 2024 – 2030
Figure-05: Disease Type – Cataplexia Market (Million US$), 2018 – 2023
Figure-06: Disease Type – Forecast for Cataplexia Market (Million US$), 2024 – 2030
Figure-07: Disease Type – Other Disease type Market (Million US$), 2018 – 2023
Figure-08: Disease Type – Forecast for Other Disease type Market (Million US$), 2024 – 2030
Figure-09: Therapeutic Type – Central Nervous Systems Stimulants Market (Million US$), 2018 – 2023
Figure-10: Therapeutic Type – Forecast for Central Nervous Systems Stimulants Market (Million US$), 2024 – 2030
Figure-11: Therapeutic Type – Tricyclic Antidepressants Market (Million US$), 2018 – 2023
Figure-12: Therapeutic Type – Forecast for Tricyclic Antidepressants Market (Million US$), 2024 – 2030
Figure-13: Therapeutic Type – Sodium Oxybate Market (Million US$), 2018 – 2023
Figure-14: Therapeutic Type – Forecast for Sodium Oxybate Market (Million US$), 2024 – 2030
Figure-15: Therapeutic Type – Selective Serotonin Reuptake Inhibitor Market (Million US$), 2018 – 2023
Figure-16: Therapeutic Type – Forecast for Selective Serotonin Reuptake Inhibitor Market (Million US$), 2024 – 2030
Figure-17: Therapeutic Type – Others Market (Million US$), 2018 – 2023
Figure-18: Therapeutic Type – Forecast for Others Market (Million US$), 2024 – 2030
Figure-19: End User – Diagnostics Centers Market (Million US$), 2018 – 2023
Figure-20: End User – Forecast for Diagnostics Centers Market (Million US$), 2024 – 2030
Figure-21: End User – Hospitals Market (Million US$), 2018 – 2023
Figure-22: End User – Forecast for Hospitals Market (Million US$), 2024 – 2030
Figure-23: End User – Others Market (Million US$), 2018 – 2023
Figure-24: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-25: United States – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-26: United States – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-27: Canada – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-28: Canada – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-29: Mexico – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-30: Mexico – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-31: Brazil – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-32: Brazil – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-33: United Kingdom – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-34: United Kingdom – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-35: Germany – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-36: Germany – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-37: France – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-38: France – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-39: Italy – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-40: Italy – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-41: Spain – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-42: Spain – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-43: Netherlands – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-44: Netherlands – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-45: China – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-46: China – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-47: Japan – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-48: Japan – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-49: India – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-50: India – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-51: South Korea – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-52: South Korea – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-53: Australia – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-54: Australia – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-55: United Arab Emirates – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-56: United Arab Emirates – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-57: South Africa – Narcolepsy Drugs Market (Million US$), 2018 – 2023
Figure-58: South Africa – Forecast for Narcolepsy Drugs Market (Million US$), 2024 – 2030
Figure-59: Jazz Pharmaceuticals – Global Revenue (Million US$), 2018 – 2023
Figure-60: Jazz Pharmaceuticals – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-61: Ligand Pharmaceuticals – Global Revenue (Million US$), 2018 – 2023
Figure-62: Ligand Pharmaceuticals – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-63: Novartis AG – Global Revenue (Million US$), 2018 – 2023
Figure-64: Novartis AG – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-65: Takeda Pharmaceutical – Global Revenue (Million US$), 2018 – 2023
Figure-66: Takeda Pharmaceutical – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-67: Teva Pharmaceutical – Global Revenue (Million US$), 2018 – 2023
Figure-68: Teva Pharmaceutical – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-69: Hikma Pharmaceuticals Plc – Global Revenue (Million US$), 2018 – 2023
Figure-70: Hikma Pharmaceuticals Plc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-71: Harmony Biosciences Holdings – Global Revenue (Million US$), 2018 – 2023
Figure-72: Harmony Biosciences Holdings – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-73: Roche Holding AG – Global Revenue (Million US$), 2018 – 2023
Figure-74: Roche Holding AG – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-75: Johnson & Johnson – Global Revenue (Million US$), 2018 – 2023
Figure-76: Johnson & Johnson – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables

Table-01: Global – Narcolepsy Drugs Market Share by Disease Type (Percent), 2018 – 2023
Table-02: Global – Forecast for Narcolepsy Drugs Market Share by Disease Type (Percent), 2024 – 2030
Table-03: Global – Narcolepsy Drugs Market Share by Therapeutic Type (Percent), 2018 – 2023
Table-04: Global – Forecast for Narcolepsy Drugs Market Share by Therapeutic Type (Percent), 2024 – 2030
Table-05: Global – Narcolepsy Drugs Market Share by End User (Percent), 2018 – 2023
Table-06: Global – Forecast for Narcolepsy Drugs Market Share by End User (Percent), 2024 – 2030
Table-07: Global – Narcolepsy Drugs Market Share by Countries (Percent), 2018 – 2023
Table-08: Global – Forecast for Narcolepsy Drugs Market Share by Countries (Percent), 2024 – 2030